cancer
second
lead
caus
death
worldwid
major
advanc
made
design
chemotherapi
agent
radiat
surgic
procedur
mortal
rate
remain
high
termin
cancer
requir
innov
therapeut
approach
current
limit
tradit
use
herb
treat
divers
human
ill
date
back
thousand
year
today
societi
use
natur
product
remedi
defin
amongst
other
classif
complementari
altern
medicin
cam
field
cam
global
interest
particular
augment
tradit
chemotherapi
prevent
cancer
remiss
serv
basic
chemoprevent
strategi
rhu
chinensi
mill
belong
genu
rhu
famili
anacardiacea
rhu
chinensi
gall
rcg
abnorm
growth
rhu
chinensi
leav
caus
chines
aphid
schlechtendalia
chinensi
also
use
decad
indigen
peopl
treatment
diarrhea
hemorrhag
inflamm
recent
studi
conduct
laboratori
highthroughput
screen
natur
product
reveal
extract
rgc
halt
prolifer
human
breast
cancer
cell
inhibit
hldha
enzym
play
signific
role
drive
aggress
malign
chemo
radiotherapi
resist
tumorigen
potenti
metastat
process
believ
abund
lactic
acid
produc
releas
tumor
cell
assist
invas
motil
low
ph
weaken
extracellular
stroma
help
tumor
cell
dislodg
burrow
blood
lymphat
system
given
potenti
valu
identif
novel
hldha
inhibitor
augment
target
cancer
therapi
investig
constitu
properti
rhu
chinensi
gallnut
isol
chemic
respons
hldha
inhibit
achiev
bioactiv
guid
fraction
theoret
molecular
dock
function
enzym
studi
follow
vitro
evalu
human
breast
cancer
cell
line
domin
protein
express
hldha
dri
rcg
g
ground
homogen
extract
ethanol
three
time
h
solut
combin
evapor
obtain
crude
extract
extract
dissolv
water
success
fraction
liquidliquid
partit
petroleum
ether
three
time
ml
ethyl
acet
six
time
ml
nbutanol
three
time
ml
yield
petroleum
ether
solubl
portion
g
ethyl
acet
solubl
portion
g
nbutanol
solubl
portion
g
watersolubl
portion
g
differ
fraction
test
hldha
unitsml
activ
concentr
rang
mgml
serial
dilut
made
use
diluent
consist
hbss
hepe
adjust
ph
dri
ethyl
acet
fraction
show
hldha
inhibitori
activ
concentr
mgml
ethyl
acet
fraction
g
flash
chromatograph
silica
gel
mesh
elut
mlmin
chloroform
methanol
gradient
solvent
system
total
ml
fraction
collect
fraction
pool
accord
r
f
valu
tlc
combin
give
distinct
fraction
evapor
yield
g
g
g
g
g
result
fraction
test
activ
mgml
fraction
show
signific
hldha
inhibitori
activ
rel
fraction
g
activ
fraction
analyz
separ
four
major
fraction
rphplc
uv
detect
nm
um
mm
column
elut
gradient
system
acetonitril
water
consist
tfa
fraction
g
show
signific
activ
compar
three
fraction
separ
rpcolumn
chromatographi
um
column
elut
acetonitril
yield
three
fraction
fraction
g
g
show
similar
activ
identifi
later
combin
substanc
extract
identifi
pgg
solid
offwhit
powder
melt
point
determin
meltemp
ii
apparatu
laboratori
devic
found
mw
nmr
spectra
nmr
spectra
pgg
concentr
whole
crude
ethanol
rcg
extract
quantifi
use
shimadzu
hplc
system
equip
uv
detector
set
nm
workstat
contain
ezstart
version
softwar
instrument
interfac
dock
water
autosampl
model
plu
shimadzu
scientif
instrument
columbia
md
usa
water
milford
usa
mobil
phase
consist
acet
acid
acetonitril
flow
rate
isocrat
mlsminut
column
use
um
mm
venusil
ab
vwr
radnor
pa
usa
pgg
extern
standard
prepar
mobil
phase
chines
gallnut
ethanol
extract
dilut
mobil
phase
inject
volum
set
ul
atcc
human
breast
cancer
cell
obtain
atcc
manassa
va
cell
brought
atccformul
leibovitz
medium
catalog
number
supplement
fb
penicillinstreptomycin
mgml
confluenc
cell
subcultur
grown
dmem
contain
phenol
red
fb
mm
lglutamin
sodium
pyruv
penicillinstreptomycin
mgml
cultur
condit
maintain
everi
day
media
replac
cell
subcultur
experi
plate
media
consist
dmem
fb
toxic
studi
fb
prolifer
studi
penicillinstreptomycin
mgml
mm
glucos
mm
sodium
pyruv
mm
lglutamin
viabl
cell
count
quantifi
use
resazurin
alamar
blue
indic
dye
work
solut
resazurin
prepar
steril
pb
phenol
red
mgml
ad
vv
sampl
sampl
return
incub
hr
reduct
dye
viabl
cell
resorufin
fluoresc
compound
quantit
analyz
use
micropl
fluoromet
model
version
cambridg
technolog
inc
watertown
set
excitationemiss
continu
hldha
assay
use
recombin
full
length
human
ldha
amino
acid
n
termin
tag
amino
acid
tag
mw
kda
enzym
commiss
ec
number
brenda
iubmb
abcam
cambridg
use
previous
confirm
ident
enzym
use
matrix
assist
laser
desorpt
ionis
maldi
mass
spectrometri
analysi
mascot
id
briefli
enzym
assay
buffer
consist
hbss
calcium
mg
ph
adjust
pgg
ad
variou
concentr
hldha
enzym
final
concentr
unitsml
adenin
dinucleotid
reduc
form
solut
final
work
concentr
preread
nm
establish
elimin
background
reaction
start
solut
contain
substrat
pyruv
final
concentr
mm
read
taken
intermitt
minut
nm
use
micropl
reader
biotek
instrument
inc
winooski
vt
usa
presenc
hldha
cell
determin
use
recombin
hldha
standard
cell
wash
centrifug
supernat
discard
use
icecold
steril
pb
pellet
resuspend
homogenizedson
ripa
lysi
buffer
contain
proteas
inhibitor
sampl
place
ice
min
centrifug
minut
supernat
ad
laemmli
sampl
buffer
biorad
number
fresh
boil
minut
approxim
protein
loadedlan
separ
use
sdspage
gel
run
buffer
mm
tri
mm
glycin
ph
biorad
appli
constant
v
constant
min
protein
transfer
polyvinyliden
fluorid
membran
v
minut
icecold
transfer
buffer
contain
mm
tri
mm
glycin
methanol
membran
place
block
buffer
consist
bovin
serum
albumin
fraction
v
bsa
wv
tb
ph
membran
wash
place
rabbit
antihuman
ldha
antibodi
contain
bsa
ttb
rt
hr
membran
wash
ttb
incub
goat
antirabbit
igg
fc
specif
peroxidas
conjug
nonfat
dri
milk
pb
hr
rt
final
wash
peroxidas
detect
sigma
fast
dab
tetrahydrochlorid
metal
enhanc
cobalt
chlorid
imag
scan
use
epson
stylu
intens
analysi
perform
use
imagej
softwar
provid
nation
institut
health
cellular
product
lactic
acid
determin
plate
use
colorimetr
enzymat
assay
procedur
number
sigma
diagnost
st
loui
mo
briefli
lactat
quantifi
convers
pyruv
use
base
lactat
reagent
contain
lactat
oxidas
ul
horseradish
peroxidas
ul
triniti
biotech
jamestown
ny
usa
reagent
ad
chromogen
sampl
incub
minut
lactat
quantifi
nm
uv
micropl
spectrophotomet
biotek
instrument
inc
winooski
vt
usa
xray
crystal
structur
human
ldh
form
predominantli
found
human
muscl
download
rcsb
protein
data
bank
pdb
chain
extract
select
dock
studi
chain
protein
refin
use
structur
prepar
tool
biopolym
modul
offer
sybylx
suit
process
mislabel
atom
type
pdb
file
correct
backbon
side
chain
repair
sidechain
bump
fix
side
chain
amid
check
maxim
potenti
hydrogen
bond
hydrogen
atom
ad
protein
protein
subject
energi
minim
follow
gradient
termin
powel
method
iter
use
forc
field
incorpor
charg
nonbond
cutoff
set
dielectr
constant
set
result
refin
protein
use
dock
purpos
conform
compound
present
studi
pgg
structur
download
pubchem
databas
subject
minim
follow
gradient
termin
conjug
gradient
method
iter
use
tripo
forc
field
incorpor
gasteigerhuckel
charg
nonbond
cutoff
set
dielectr
constant
set
thu
optim
compound
pgg
dock
catalyt
activ
site
chain
ldh
protein
complex
pdb
use
high
precis
surlexdock
geomx
program
implement
sybyl
softwar
increment
construct
approach
build
structur
activ
site
favor
bind
affin
process
initi
protomol
gener
use
bound
ligand
adenin
dinucleotid
nai
allow
us
map
activ
site
dock
test
ligand
pgg
entir
dock
process
ring
flexibl
ligand
consid
predock
postdock
minim
perform
selfscor
term
includ
optimum
result
statist
analysi
perform
use
graph
pad
prism
version
graph
pad
softwar
inc
san
diego
ca
usa
determin
regress
analysi
use
origin
softwar
originlab
northampton
signific
differ
multipl
group
assess
use
oneway
anova
follow
bonferroni
multipl
comparison
test
student
ttest
highthroughput
screen
identifi
rhu
chinensi
gallnut
ethanol
extract
inhibitori
activ
human
recombin
hldha
previous
report
one
potent
natur
product
elucid
order
elucid
activ
constitu
within
rcg
extract
respons
hldha
inhibit
bioactiv
guid
fraction
figur
conduct
hldha
activ
inhibit
ethyl
acet
fraction
figur
b
c
yield
two
activ
fraction
within
figur
fraction
g
g
show
similar
activ
identifi
later
combin
molecul
identifi
pgg
solid
offwhit
substanc
melt
point
determin
meltemp
ii
apparatu
laboratori
devic
found
mw
nmr
spectra
nmr
spectra
quantif
valid
pgg
rcg
extract
accomplish
hplc
figur
extern
standard
b
versu
extract
indic
pgg
present
equival
crude
extract
assess
pgg
could
theoret
inhibit
hldha
molecular
dock
studi
conduct
data
show
predict
competit
bind
pgg
figur
within
nadh
bind
cofactor
site
hldha
enzym
figur
b
c
dock
studi
show
h
bond
interact
dock
ligand
pgg
protein
cofactor
site
figur
b
figur
compound
pgg
dock
alongsid
bound
ligand
adenin
dinucleotid
nai
total
score
express
k
obtain
respect
pgg
bound
ligand
nia
respect
effect
also
confirm
function
studi
figur
pgg
found
extrem
potent
hldha
inhibitor
within
therapeut
rang
nm
compar
known
hldha
inhibitor
oxal
acid
figur
b
demonstr
rel
weak
potenc
reflect
mm
competit
bind
pgg
versu
nadh
clearli
show
site
greater
affin
pgg
nadh
figur
order
determin
effect
pgg
vitro
human
breast
cancer
cell
line
lysat
evalu
baselin
express
hldha
western
blot
figur
find
valid
ident
recombin
protein
use
studi
well
demonstr
domin
express
level
cell
subject
vitro
effect
incur
pgg
vitro
analys
lethal
pgg
versu
reduct
lactic
acid
accumul
supernat
near
ident
figur
b
howev
given
toxic
compound
regardless
mechan
action
reduc
lactic
acid
process
cell
death
tumor
cell
conclus
drawn
data
loss
lactat
significantli
preced
cell
death
one
could
say
correl
analysi
requir
antiprolif
effect
pgg
rel
paclitaxel
evalu
threeday
growth
period
figur
studi
provid
data
support
pgg
compon
rgc
extract
inhibit
human
ldha
halt
prolifer
human
tumor
cell
line
highli
express
human
ldha
protein
data
studi
confirm
pgg
compon
newli
identifi
hldha
inhibitor
potenti
applic
cam
use
cancer
treatment
work
supportsbuild
find
other
describ
therapeut
valu
molecul
anticanc
agent
establish
suppress
prostat
cancer
metastasi
angiogenesi
capac
initi
apoptosi
halt
cell
cycl
phase
dna
replic
sphase
correspond
primari
basi
propos
therapeut
use
treatment
cancer
time
rgc
extract
whole
equal
capabl
inhibit
angiogenesi
induc
apoptosi
cancer
cell
cytostat
agent
moreov
medicin
valu
describ
scientif
literatur
multidimension
therapeut
valu
also
effect
harm
intestin
periodont
bacteria
hepat
carcinoma
viru
sever
acut
respiratori
syndrom
corona
antiinflammatori
data
studi
also
confirm
abil
pgg
inhibit
hldha
therapeut
target
particular
given
role
tumor
initi
progress
metastasi
aggress
malign
pheochromocytoma
paraganglioma
breast
cancer
interestingli
ldh
specif
therapeut
target
tumor
cell
exact
mechan
action
exert
anticanc
effect
remain
unknown
believ
elev
hldha
protein
express
tumor
cell
subsequ
product
lactic
acid
contribut
develop
radiat
chemotherapi
resist
tumor
cell
overproduct
lactic
acid
absenc
presenc
describ
almost
centuri
ago
otto
warburg
term
warburg
effect
mani
scientist
theoriz
aberr
function
alter
metabol
studi
laboratori
explor
phenomenon
use
current
technolog
wholegenom
proteom
malditofm
metabolit
analysi
show
warburg
effect
function
role
metabol
regul
acid
pericellular
ph
phe
unknown
reason
cancer
cell
inher
thrive
slightli
acid
ph
extrem
vulner
necrosi
ph
shift
toward
alkalin
sustain
steadi
state
ph
metabol
invers
fluctuat
domin
glycolyticr
substrat
level
phosphoryl
slp
mitochondri
mt
oxid
phosphoryl
control
lactic
acid
product
case
hldha
would
compris
vehicl
maintain
acid
ph
tumor
cell
thrive
question
much
work
still
remain
tumor
cell
requir
ampl
concentr
acid
acid
alon
trigger
aggress
form
malign
augment
metastas
initi
chemoresist
correl
low
surviv
rate
data
collect
lab
other
seem
indic
acid
turn
anabol
process
tumor
cell
due
energi
effici
elev
protein
express
nutrient
sensor
g
protein
beta
protein
subunitlik
compon
mtor
mammalian
target
rapamycin
signal
downstream
tumor
promot
target
chang
indic
feedback
sensor
acid
could
switch
metabol
state
tumor
cell
anabol
catabol
exact
role
hldha
remain
elus
known
hldha
knockdown
lower
function
capac
hldha
lead
suppress
tumor
growth
metastasi
indic
enzym
novel
target
cancer
therapi
strategi
studi
provid
data
support
therapeut
efficaci
pgg
compon
rgc
extract
inhibit
human
ldha
halt
prolifer
human
tumor
cell
line
highli
express
hldha
protein
pentagalloylglucos
pgg
compon
rgc
show
remark
competit
inhibitori
activ
hldha
nadh
cofactor
dock
site
effect
tumor
cell
bare
high
express
hldha
result
block
prolifer
futur
research
requir
determin
detail
causeeffect
relationship
hldha
inhibit
biochem
metabol
process
relat
effect
tumor
cell
